Sitemap
Pages
Blog Archives
Archives by Month
- March 2021
- July 2020
- March 2020
- August 2019
- May 2019
- March 2019
- February 2019
- November 2018
- October 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- August 2016
- June 2016
- May 2016
- March 2016
- February 2016
- January 2016
- January 2015
- December 2014
- September 2014
- June 2014
- April 2014
- March 2014
- September 2013
- May 2013
- April 2013
- March 2013
- February 2013
Archives by Category
Archives by Tag
- No categories
Archives by Author
Latest 20 Posts
- BDA: COVID-19 measures affecting clinical trials submissions
- Bulgaria and the CESP system
- BDA: further measures related to COVID-19
- Bulgaria: State of Emergency*
- Romania: the drug agency announced restrictions related to COVID-19*
- The Pharma Legal Handbook: Bulgaria
- Changes at the Romanian Drug Agency
- Bulgaria is included in the GMP Mutual Recognition Agreement between EU and USA
- Brexit: the exemption for quality control testing
- Bulgaria: managing alerts during verification and decommissioning of medicines
- How to use the defective product report to notify a quality defect to the Romanian Drug Agency
- Bulgarian Drug Agency: reduced timelines for manufacturing authorisations and wholesale distribution licenses
- Bulgaria changes the structure of its ethics committees in clinical trials
- BDA: new requirements for the “proof of payment” document
- The Bulgarian Drug Agency initiates PIC/S membership procedure
- BDA: Guidance on the implementation of safety features in Bulgaria
- 10 Years Anniversary
- PharmDedict on Pharma Boardroom
- EudraVigilance Go-Live: expecting 22 November 2017
- The first MRP with RMS Bulgaria is now on track